The link between early life blood sugar levels and Alzheimer's disease markers in middle age.
Official title: Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study
Funded at Tulane University of Louisiana · NIH-10535457 · Data updated 2026-11-12
This study is looking at how blood sugar levels in early life might affect brain health and the risk of Alzheimer's disease later on, and it's for middle-aged people who want to understand how their early life health could impact their memory and thinking in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | February 15, 2019 |
| Project end | November 30, 2025 |
| Funding year | 2023 |
| Award (this year) | $692,710 |
| NIH project number | 5R01AG062309-05 |
| Project ID | NIH-10535457 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who experienced metabolic dysfunction or abnormal glycemic levels during childhood or adolescence.
✕Less likely to help
Patients who have not experienced any metabolic dysfunction or who are not at risk for Alzheimer's disease may not benefit from this research.
What this research studies
This research investigates how glycemic status during early life may influence the development of Alzheimer's disease neuroimaging markers in middle-aged individuals. By examining the relationship between metabolic dysfunction and brain health, the study aims to identify potential risk factors that could be modified to prevent cognitive decline. Participants will undergo neuroimaging and assessments to evaluate brain changes associated with early life blood sugar levels. The findings could provide insights into how early interventions might mitigate the risk of Alzheimer's disease later in life.
Why it matters
Potential benefit: If successful, this research could lead to strategies for preventing Alzheimer's disease by addressing early life metabolic health.
How similar studies have gone: Previous research has indicated that early life factors can significantly impact long-term cognitive health, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Tulane University of Louisiana
New Orleans, United States Active
Researchers
- Principal investigator: Bazzano, Lydia — Tulane University of Louisiana
- Study coordinator: Bazzano, Lydia
Related research
Other NIH-funded projects on the same topics.
-
How adult children's education and economic situation affect parents' Alzheimer’s risk and outcomes
This project looks at whether adult children's education and financial resources affect older parents' chances of getting Alzheimer’s and how well parents do if they have dementia.
-
How adult children's socio-economic status affects their parents' risk of Alzheimer's disease.
This study looks at how the education and financial situation of adult children can affect the risk of Alzheimer's and related dementias in their aging parents, aiming to find ways to help keep older adults healthier based on their children's support.
-
Exploring how helping others may improve cognitive function and reduce Alzheimer's risk in older adults.
This study is looking at how helping others, like volunteering or lending a hand, can boost brain health in older adults, especially in African American communities, to see if these good deeds might help prevent or slow down Alzheimer's Disease.
-
How cardiovascular genetics and APOE ε4 status affect amyloid levels in early Alzheimer's disease
This study is looking at how certain genes and the presence of the APOE ε4 gene might affect the buildup of amyloid plaques in people who are at risk for Alzheimer's disease, especially those with conditions like high cholesterol and high blood pressure, to see if there are ways to protect against Alzheimer's.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.